Sugi Predict

Sugi Predict / Compounds / SCHEMBL6844856

SCHEMBL6844856

SCHEMBL6844856

COc1c(-c2ccsc2)ccc(CS(=O)(=O)c2ccccc2)c1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 2/20 0.40
▸ IDH2 P48735 5/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ TUBB4A P04350 2/20 0.37
▸ TUBB P07437 2/20 0.37
▸ TUBA3C P0DPH7 2/20 0.37
▸ TUBA1B P68363 2/20 0.37
▸ TUBA4A P68366 2/20 0.37
▸ TUBB4B P68371 2/20 0.37
▸ TUBB3 Q13509 2/20 0.37
▸ TUBB2A Q13885 2/20 0.37
▸ TUBB8 Q3ZCM7 2/20 0.37
▸ TUBA3E Q6PEY2 2/20 0.37
▸ TUBA1A Q71U36 2/20 0.37
▸ TUBA1C Q9BQE3 2/20 0.37
▸ TUBB6 Q9BUF5 2/20 0.37
▸ TUBB2B Q9BVA1 2/20 0.37
▸ TUBB1 Q9H4B7 2/20 0.37
▸ KEAP1 Q14145 5/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1648416 0.92 KDM4E (0.40) HSD11B1IDH2ALDH1A1L3MBTL1TUBB4A
SCHEMBL1647754 0.87 KMT2A (0.43) HSD11B1ALDH1A1L3MBTL1KEAP1NFE2L2
SCHEMBL1648035 0.83 KEAP1 (0.38) HSD11B1ALDH1A1L3MBTL1KEAP1NFE2L2
SCHEMBL1648227 0.83 PTGS2 (0.40) HSD11B1ALDH1A1TUBB4ATUBBTUBA3C
SCHEMBL1647713 0.82 ERN1 (0.39) HSD11B1ALDH1A1L3MBTL1KEAP1NFE2L2
SCHEMBL1647756 0.80 METAP2 (0.53) HSD11B1ALDH1A1L3MBTL1TUBB4ATUBB
SCHEMBL18801055 0.79 SLC37A4 (0.38) IDH2L3MBTL1TUBB4ATUBBTUBA3C
SCHEMBL1648084 0.79 ALDH1A1 (0.43) HSD11B1ALDH1A1L3MBTL1KEAP1NFE2L2
SCHEMBL1646328 0.79 ALDH1A1 (0.39) ALDH1A1L3MBTL1TUBB4ATUBBTUBA3C
SCHEMBL1648340 0.79 METAP2 (0.50) HSD11B1ALDH1A1L3MBTL1KEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2486004-B1 SULPHONE COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY ZAFGEN INC (US) 2017-05-03 — — EP disclosed
US-9067905-B2 Sulphone compounds and methods of making and using same ZAFGEN, INC. (US) 2015-06-30 — — US disclosed
US-9067905-B2 Sulphone compounds and methods of making and using same ZAFGEN, INC. (US) 2015-06-30 — — US disclosed
US-20130053364-A1 Sulphone Compounds and Methods of Making and Using Same ZAFGEN, INC. 2013-02-28 — — US disclosed
US-20130053364-A1 Sulphone Compounds and Methods of Making and Using Same ZAFGEN, INC. 2013-02-28 — — US disclosed
WO-2011044506-A2 SULPHONE COMPOUNDS AND METHODS OF MAKING AND USING SAME ZAFGEN CORPORATION (US) 2011-04-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053364-A1 Sulphone Compounds and Methods of Making and Using Same METAP2, DNPEP, STS HSD11B1 421/4885IDH2 821/4885ALDH1A1 360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.